Skip to main content
Premium Trial:

Request an Annual Quote

Berlin Institute for Medical Systems Biology to Install PacBio RS

Premium

The Berlin Institute for Medical Systems Biology, which is part of the Max Delbrück Center for Molecular Medicine in Germany, has purchased a PacBio RS single-molecule sequencer from Pacific Biosciences, the institute said this week.

The sequencer will be installed at BIMSB in early September, complementing other next-generation sequencing technologies housed in its Scientific Genomics Platform. Currently, the institute has two Illumina HiSeq 2000, two Illumina GAIIx, one 454 GS FLX, and two Life Technologies SOLiD instruments.

BIMSB plans to use the PacBio RS to study gene regulation, RNA function, epigenetics, and genome structure.

The institute was launched by the Max Delbrück Center in 2008 with start-up funding from the German Federal Ministry of Education and Research and the senate of Berlin.

The Scan

Breast Cancer Risk Related to Pathogenic BRCA1 Mutation May Be Modified by Repeats

Several variable number tandem repeats appear to impact breast cancer risk and age at diagnosis in almost 350 individuals carrying a risky Ashkenazi Jewish BRCA1 founder mutation.

Study Explores Animated Digital Message Approach to Communicate Genetic Test Results to Family Members

In the Journal of Genetic Counseling, the approach showed promise in participants presented with a hypothetical scenario related to a familial hereditary breast and ovarian cancer syndrome diagnosis.

Computational Tool Predicts Mammalian Messenger RNA Degradation Rates

A tool called Saluki, trained with mouse and human messenger RNA data, appears to improve mRNA half-life predictions by taking RNA and genetic features into account, a Genome Biology paper reports.

UK Pilot Study Suggests Digital Pathway May Expand BRCA Testing in Breast Cancer

A randomized pilot study in the Journal of Medical Genetics points to similar outcomes for breast cancer patients receiving germline BRCA testing through fully digital or partially digital testing pathways.